1. Home
  2. PLBC vs SCLX Comparison

PLBC vs SCLX Comparison

Compare PLBC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBC
  • SCLX
  • Stock Information
  • Founded
  • PLBC 1980
  • SCLX 2011
  • Country
  • PLBC United States
  • SCLX United States
  • Employees
  • PLBC N/A
  • SCLX N/A
  • Industry
  • PLBC Finance Companies
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLBC Finance
  • SCLX Health Care
  • Exchange
  • PLBC Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • PLBC 220.3M
  • SCLX 143.6M
  • IPO Year
  • PLBC 2005
  • SCLX N/A
  • Fundamental
  • Price
  • PLBC $40.80
  • SCLX $1.11
  • Analyst Decision
  • PLBC Buy
  • SCLX Strong Buy
  • Analyst Count
  • PLBC 1
  • SCLX 3
  • Target Price
  • PLBC $40.00
  • SCLX $8.00
  • AVG Volume (30 Days)
  • PLBC 7.3K
  • SCLX 184.3K
  • Earning Date
  • PLBC 10-16-2024
  • SCLX 08-13-2024
  • Dividend Yield
  • PLBC 2.61%
  • SCLX N/A
  • EPS Growth
  • PLBC N/A
  • SCLX N/A
  • EPS
  • PLBC 4.80
  • SCLX N/A
  • Revenue
  • PLBC $78,618,000.00
  • SCLX $50,833,000.00
  • Revenue This Year
  • PLBC N/A
  • SCLX $89.87
  • Revenue Next Year
  • PLBC $33.17
  • SCLX N/A
  • P/E Ratio
  • PLBC $8.61
  • SCLX N/A
  • Revenue Growth
  • PLBC 5.13
  • SCLX 9.41
  • 52 Week Low
  • PLBC $32.50
  • SCLX $0.73
  • 52 Week High
  • PLBC $45.00
  • SCLX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • PLBC 59.77
  • SCLX 35.91
  • Support Level
  • PLBC $39.37
  • SCLX $1.02
  • Resistance Level
  • PLBC $41.37
  • SCLX $1.12
  • Average True Range (ATR)
  • PLBC 0.65
  • SCLX 0.08
  • MACD
  • PLBC 0.10
  • SCLX 0.01
  • Stochastic Oscillator
  • PLBC 88.28
  • SCLX 35.92

About PLBC Plumas Bancorp

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: